Voyager Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 164
EBIT TTM (mln): 9
index 0 1 2 3 4 5 6 7 8 9 10 11
Rok finansowy 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 17 14 10 8 104 171 37 41 250 80
Przychód Δ r/r 0.0% 0.0% inf% -18.0% -28.7% -24.8% 1270.1% 63.9% -78.1% 9.3% 511.2% -68.0%
Marża brutto -inf% 0.0% 100.0% 100.0% 100.0% 100.0% -14.7% 36.4% -97.2% 84.9% 98.2% 100.0%
EBIT (mln) -8 -14 -20 -41 -72 -91 -52 27 -74 -51 122 -83
EBIT Δ r/r 0.0% 90.7% 41.0% 103.9% 74.0% 26.8% -43.3% -153.0% -368.8% -30.9% -340.0% -168.3%
EBIT (%) 0.0% 0.0% -116.8% -290.4% -709.1% -1195.6% -49.5% 16.0% -196.8% -124.3% 48.8% -104.1%
Koszty finansowe (mln) 0 0 0 1 0 0 0 0 -0 2 0 0
EBITDA (mln) 0 -14 -20 -41 -72 -91 -52 31 -74 -51 126 -83
EBITDA(%) 0.0% 0.0% -116.8% -290.4% -709.1% -1195.6% -49.5% 18.2% -196.8% -124.3% 50.6% -104.1%
Podatek (mln) -0 0 -1 0 -2 -0 -3 -2 -5 0 1 1
Zysk Netto (mln) -8 -16 -30 -40 -71 -88 -41 37 -66 -46 132 -65
Zysk netto Δ r/r 0.0% 112.8% 81.8% 35.5% 75.9% 24.9% -53.8% -190.0% -279.7% -29.7% -385.1% -149.1%
Zysk netto (%) 0.0% 0.0% -171.2% -282.7% -697.6% -1158.8% -39.1% 21.5% -176.5% -113.4% 52.9% -81.3%
EPS -16.552 -1.11 -7.08 -1.59 -2.64 -2.75 -1.14 0.99 -1.75 -1.21 3.08 -1.13
EPS (rozwodnione) -16.552 -1.11 -7.08 -1.59 -2.64 -2.75 -1.14 0.98 -1.75 -1.21 2.97 -1.13
Ilośc akcji (mln) 0 15 4 25 27 32 36 37 38 38 43 58
Ważona ilośc akcji (mln) 0 15 4 25 27 32 36 37 38 38 45 58
Waluta USD USD USD USD USD USD USD USD USD USD USD USD